Expert: The ‘Risks Don't Outweigh the Benefits’ to Getting Children Vaccinated Against COVID-19


Hannah Fish, PharmD, National Community Pharmacists Association associate director of Strategic Initiatives, discusses the next phase of the COVID-19 vaccination rollout following the FDA expanding the Pfizer-BioNTech COVID-19 vaccine EUA to include children ages 12 and older.

Pharmacy Times® interviewed Hannah Fish, PharmD, associate director of Strategic Initiatives at National Community Pharmacists Association (NCPA), on the next phase of the COVID-19 vaccination rollout following the FDA updating the Pfizer-BioNTech COVID-19 vaccine emergency use authorization (EUA) to be expanded to include children ages 12 years and older.

NCPA partnered with the COVID-19 Vaccine Education and Equity Project, a coalition of over 200 patient, provider, and public health organizations, to help to promote the update to the Pfizer-BioNTech vaccine EUA, as well as to further advance public education and equity around COVID-19 vaccines more broadly.

During the discussion, Fish detailed the process for pharmacies that are shifting to allow this expanded age group to be signed up for the Pfizer-BioNTech vaccine, the importance of COVID-19 vaccination within this younger age group, and some of the challenges that may arise in the rollout of vaccinations for this new age group.

Fish explained that although the eligibility expansion of the Pfizer-BioNTech vaccine is really exciting news and a great opportunity for both children and parents, there's going to be a flood of questions as parents seek answers to alleviate any concerns they may have regarding their children’s safety.

“I think it's the same concerns that we've been hearing the entire time. It’s concerns about the development of the vaccine being too fast,” Fish said. “The numbers might not have been as large as they would hope to study a vaccine with, but we know that the process has been rigorous. They enrolled as many people as they could to try to study this vaccine, and the risks definitely don't outweigh the benefits of having children vaccinated.”

Fish noted that the challenges in the rollout for this age group will most likely be ensuring parents understand why the vaccine should be given to their children and helping children understand the benefits of being vaccinated as well.

“I think we're going to keep combating that hesitancy that we've heard of, and really, as pharmacists, we're right there to answer those questions. We have the ability to go out and meet these patients where they are, both parents and the kids,” Fish said. “Pharmacists are in the community and ready to answer those questions.”

The discussion also included whether schools may require COVID-19 vaccinations in order for children in the newly eligible age group to return to in-person schooling in the fall, what is on the horizon in the ongoing rollout of COVID-19 vaccinations in the country, and what the role of the pharmacist is in vaccinating this new age group against COVID-19.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.